MySpark Generation Patient Support Services

Spark Therapeutics Generation Patient Services offers support to patients with confirmed biallelic RPE65 gene mutation-associated retinal dystrophy. The program provides a support team, assists with navigating insurance coverage, connects patients with financial assistance resources, and helps coordinate visits to treatment centers. Enrollment is voluntary for eligible patients.